Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular Degeneration.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2021.1660
Abstract: Importance Poor adherence or persistence to treatment can be a barrier to optimizing clinical practice (real-world) outcomes to intravitreal injection therapy in patients with neovascular age-related macular degeneration (nAMD). Currently, there is a lack of… read more here.
Keywords: vascular endothelial; nonadherence nonpersistence; treatment; anti vascular ... See more keywords
Mathematical models for the effect of anti-vascular endothelial growth factor on visual acuity.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of mathematical biology"
DOI: 10.1007/s00285-020-01544-4
Abstract: The standard of care treatment for neovascular age-related macular degeneration, delivered as ocular injection, is based on anti-vascular endothelial growth factor (anti-VEGF). The course of treatment may need to be modified quickly for certain patients… read more here.
Keywords: growth factor; endothelial growth; anti vascular; vascular endothelial ... See more keywords
Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia
Sign Up to like & getrecommendations! Published in 2019 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-019-04520-x
Abstract: Purpose To evaluate central macular thickness (CMT), subfoveal choroidal thickness (SFCT), and visual outcomes following different intravitreal anti-vascular endothelial growth factor (VEGF) treatments in eyes with subretinal neovascular membrane (SRNVM) due to type 2 proliferative… read more here.
Keywords: visual outcomes; vascular endothelial; anti vascular; outcomes following ... See more keywords
The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization
Sign Up to like & getrecommendations! Published in 2022 at "International Ophthalmology"
DOI: 10.1007/s10792-022-02261-1
Abstract: To evaluate anatomical and visual results of eyes with naive myopic choroidal neovascularization (mCNV) in patients treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapies. This is a retrospective, non-randomized, comperative, intervetional study. One hundred… read more here.
Keywords: ivr; vascular endothelial; myopic choroidal; choroidal neovascularization ... See more keywords
Nanoparticles for Multimodal Antivascular Therapeutics: Dual Drug Release, Photothermal and Photodynamic Therapy.
Sign Up to like & getrecommendations! Published in 2019 at "Acta biomaterialia"
DOI: 10.1016/j.actbio.2019.11.004
Abstract: The poor delivery of nanoparticles to target cancer cells hinders their success in the clinical setting. In this work, an alternative target readily available for circulating nanoparticles has been selected to eliminate the need for… read more here.
Keywords: nanoparticles multimodal; multimodal antivascular; anti vascular; drug ... See more keywords
Response to treatment with intravitreal anti-vascular endothelial growth factors in bilateral exudative cuticular drusen
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2021.101110
Abstract: Purpose To present the response to treatment with anti-vascular endothelial growth factor (VEGF) agents of exudative cuticular drusen (CD) in a patient who developed temporary suspended scattering particles in motion (SSPiM) after injection in the… read more here.
Keywords: vascular endothelial; treatment; anti vascular; response treatment ... See more keywords
Hemodynamic and structural changes in retinal arterial macroaneurysm after intravitreal anti-vascular endothelial growth factor injection
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2021.101182
Abstract: High resolution imaging with optical coherence tomography angiography and offset pinhole adaptive optics scanning light ophthalmoscope helped us visualize the hemodynamic and structural changes in a ruptured retinal arterial macroaneurysm in a 78-year-old woman. Intravitreal… read more here.
Keywords: structural changes; hemodynamic structural; vascular endothelial; anti vascular ... See more keywords
The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown
Sign Up to like & getrecommendations! Published in 2021 at "Photodiagnosis and Photodynamic Therapy"
DOI: 10.1016/j.pdpdt.2021.102449
Abstract: Purpose : To assess the clinical status of treatment-naive patients who had to delay 3-dose loading anti-VEGF (anti-vascular endothelial growth factor) injections during the COVID-19 lockdown, and to evaluate the effect of the delayed visual… read more here.
Keywords: vascular endothelial; endothelial growth; covid lockdown; treatment ... See more keywords
One-year comparison of anti-vascular endothelial growth factor and half-dose photodynamic therapies for pachychoroid neovasculopathy
Sign Up to like & getrecommendations! Published in 2021 at "Eye"
DOI: 10.1038/s41433-021-01418-z
Abstract: To compare 1-year outcomes between anti-vascular endothelial factor (VEGF) therapy and half-dose photodynamic therapy (PDT) for treatment-naive pachychoroid neovasculopathy (PNV) with subretinal fluid (SRF). Consecutive patients with treatment-naive PNV patients with SRF treated with intravitreal… read more here.
Keywords: half dose; treatment; year; anti vascular ... See more keywords
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-25688-y
Abstract: Vascular disrupting agents as DMXAA inhibit tumor growth only for a short period of time followed by rapid tumor regrowth. Among others, hypoxia and presence of transcription factor HIF-1α are responsible for tumors regrowth. The… read more here.
Keywords: combination; hif; digoxin; anti vascular ... See more keywords
Long term results of three anti-vascular endothelial growth factor agents in pachychoroid neovasculopathy
Sign Up to like & getrecommendations! Published in 2022 at "Cutaneous and Ocular Toxicology"
DOI: 10.1080/15569527.2022.2068150
Abstract: Abstract Purpose To assess morphological changes and visual results in eyes with pachychoroid neovasculopathy (PNV) that underwent different intravitreal anti-vascular endothelial growth factor (VEGF) agents. Materials and methods This is a retrospective, observational, comparative study… read more here.
Keywords: pachychoroid neovasculopathy; endothelial growth; group; anti vascular ... See more keywords